Clinical Trials Browser

Terminated × Lymphoma, T-Cell, Peripheral × Alemtuzumab × Clear all

NCT00441025 2009-06-25

The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL

Phase 2 Terminated

Lymphoma, T-Cell, Peripheral